Traws Pharma

PriceTraws Pharma

TRAW

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Historical stock price chart and annual return over the past years

-99%

5 years

% Total

TRAW
-60%

5 years

Annual Return

TRAW